Down-regulation of the stathmin/Op18 and FKBP25 genes following p53 induction

被引:108
作者
Ahn, J
Murphy, M
Kratowicz, S
Wang, A
Levine, AJ
George, DL
机构
[1] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA
[2] Fox Chase Canc Ctr, Dept Pharmacol, Philadelphia, PA 19111 USA
[3] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA
关键词
p53; repression; stathmin; FKBP25;
D O I
10.1038/sj.onc.1202986
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p53 tumor suppressor protein can function as an activator and a repressor of gene transcription. Currently, the mechanism of transcriptional repression by p53 is poorly understood. To aid in clarifying this mechanism, we carried out studies designed to identify specific target genes that are down-regulated following p53 induction. Among the negative p53-response genes revealed by our screening protocols are those encoding stathmin (Op18), a tubulin-associated protein implicated in cell signaling pathways, and an FK506/rapamycin-binding protein, FKBP25. Stathmin and FKBP25 exhibit decreased expression in both human and murine immortalized and transformed cell lines following induction of wild-type p53 by several stimuli that result in DNA damage. Candidate p53-repressed genes such as these provide the necessary markers to delineate the mechanism and biological consequences of transcriptional repression mediated by p53.
引用
收藏
页码:5954 / 5958
页数:5
相关论文
共 34 条
  • [1] MDM2 EXPRESSION IS INDUCED BY WILD TYPE-P53 ACTIVITY
    BARAK, Y
    JUVEN, T
    HAFFNER, R
    OREN, M
    [J]. EMBO JOURNAL, 1993, 12 (02) : 461 - 468
  • [2] Identification of a protein that interacts with tubulin dimers and increases the catastrophe rate of microtubules
    Belmont, LD
    Mitchison, TJ
    [J]. CELL, 1996, 84 (04) : 623 - 631
  • [3] Overexpression of the stathmin gene in a subset of human breast cancer
    Bièche, I
    Lachkar, S
    Becette, V
    Cifuentes-Diaz, C
    Sobel, A
    Lidereau, R
    Curmi, PA
    [J]. BRITISH JOURNAL OF CANCER, 1998, 78 (06) : 701 - 709
  • [4] BRATTSAND G, 1993, LEUKEMIA, V7, P569
  • [5] WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION
    ELDEIRY, WS
    TOKINO, T
    VELCULESCU, VE
    LEVY, DB
    PARSONS, R
    TRENT, JM
    LIN, D
    MERCER, WE
    KINZLER, KW
    VOGELSTEIN, B
    [J]. CELL, 1993, 75 (04) : 817 - 825
  • [6] The p53 tumor suppressor inhibits transcription of the TATA-less mouse DP1 promoter
    Gopalkrishnan, RV
    Lam, EWF
    Kedinger, C
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (18) : 10972 - 10978
  • [7] p53 in growth control and neoplasia
    Gottlieb, TM
    Oren, M
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1996, 1287 (2-3): : 77 - 102
  • [8] HANASH SM, 1988, J BIOL CHEM, V263, P12813
  • [9] P53 ALTERATION IS A COMMON EVENT IN THE SPONTANEOUS IMMORTALIZATION OF PRIMARY BALB/C MURINE EMBRYO FIBROBLASTS
    HARVEY, DM
    LEVINE, AJ
    [J]. GENES & DEVELOPMENT, 1991, 5 (12B) : 2375 - 2385
  • [10] Mdm2 promotes the rapid degradation of p53
    Haupt, Y
    Maya, R
    Kazaz, A
    Oren, M
    [J]. NATURE, 1997, 387 (6630) : 296 - 299